UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From to

Commission File Number 001-37845

MICROSOFT CORPORATION

Washington

91-1144442

(STATE OF INCORPORATION)

(I.R.S. ID)

ONE MICROSOFT WAY, REDMOND, Washington 98052-6399

(425) 882-8080

www.microsoft.com/investor

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of exchange on which registered

Common stock, $0.00000625 par value per share

MSFT

Nasdaq

3.125% Notes due 2028

MSFT

Nasdaq

2.625% Notes due 2033

MSFT

Nasdaq

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

Accelerated Filer

Non-accelerated Filer

Smaller Reporting Company

Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

Indicate the number of shares outstanding of each of the issuer s classes of common stock, as of the latest practicable date.

Class

Outstanding as of April 22, 2024

Common Stock, $0.00000625 par value per share

7,432,305,794 shares

MICROSOFT CORPORATION

FORM 10-Q

For the Quarter Ended March 31, 2024

INDEX

Page

PART I.

FINANCIAL INFORMATION

Item 1.

Financial Statements

a)

Income Statements for the Three and Nine Months Ended March 31, 2024 and 2023

b)

Comprehensive Income Statements for the Three and Nine Months Ended March 31, 2024 and 2023

c)

Balance Sheets as of March 31, 2024 and June 30, 2023

d)

Cash Flows Statements for the Three and Nine Months Ended March 31, 2024 and 2023

e)

Stockholders Equity Statements for the Three and Nine Months Ended March 31, 2024 and 2023

f)

Notes to Financial Statements

g)

Report of Independent Registered Public Accounting Firm

31

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of Operations

32

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

49

Item 4.

Controls and Procedures

49

PART II.

OTHER INFORMATION

Item 1.

Legal Proceedings

50

Item 1A.

Risk Factors

50

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

64

Item 5.

Other Information

65

Item 6.

Exhibits

66

SIGNATURE

67

PART I

Item 1

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

INCOME STATEMENTS

(In millions, except per share amounts) (Unaudited)

Three Months Ended

March 31,

Nine Months Ended

March 31,

2024

2023

2024

2023

Revenue:

Product

17,080

15,588

51,556

47,846

Service and other

44,778

37,269

128,839

107,880

Total revenue

61,858

52,857

180,395

155,726

Cost of revenue:

Product

4,339

3,941

13,834

13,933

Service and other

14,166

12,187

40,596

35,135

Total cost of revenue

18,505

16,128

54,430

49,068

Gross margin

43,353

36,729

125,965

106,658

Research and development

7,653

6,984

21,454

20,456

Sales and marketing

6,207

5,750

17,640

16,555

General and administrative

1,912

1,643

5,363

5,378

Operating income

27,581

22,352

81,508

64,269

Other income (expense), net

(854

321

(971

315

Income before income taxes

26,727

22,673

80,537

64,584

Provision for income taxes

4,788

4,374

14,437

12,304

Net income

21,939

18,299

66,100

52,280

Earnings per share:

Basic

2.95

2.46

8.90

7.02

Diluted

2.94

2.45

8.85

6.99

Weighted average shares outstanding:

Basic

7,431

7,441

7,431

7,450

Diluted

7,472

7,464

7,467

7,474

Refer to accompanying notes.

PART I

Item 1

COMPREHENSIVE INCOME STATEMENTS

(In millions) (Unaudited)

Three Months Ended

March 31,

Nine Months Ended

March 31,

2024

2023

2024

2023

Net income

21,939

18,299

66,100

52,280

Other comprehensive income (loss), net of tax:

Net change related to derivatives

10

(9

28

(34

Net change related to investments

(202

753

869

(796

Translation adjustments and other

(294

69

11

(136

Other comprehensive income (loss)

(486

813

908

(966

Comprehensive income

21,453

19,112

67,008

51,314

Refer to accompanying notes.

PART I

Item 1

BALANCE SHEETS

(In millions) (Unaudited)

March 31,

2024

June 30,

2023

Assets

Current assets:

Cash and cash equivalents

19,634

34,704

Short-term investments

60,387

76,558

Total cash, cash equivalents, and short-term investments

80,021

111,262

Accounts receivable, net of allowance for doubtful accounts of $616 and $650

44,029

48,688

Inventories

1,304

2,500

Other current assets

21,826

21,807

Total current assets

147,180

184,257

Property and equipment, net of accumulated depreciation of $74,945 and $68,251

121,375

95,641

Operating lease right-of-use assets

17,371

14,346

Equity and other investments

14,807

9,879

Goodwill

119,163

67,886

Intangible assets, net

28,828

9,366

Other long-term assets

35,551

30,601

Total assets

484,275

411,976

Liabilities and stockholders equity

Current liabilities:

Accounts payable

18,087

18,095

Short-term debt

20,535

Current portion of long-term debt

2,249

5,247

Accrued compensation

10,432

11,009

Short-term income taxes

7,311

4,152

Short-term unearned revenue

41,888

50,901

Other current liabilities

18,023

14,745

Total current liabilities

118,525

104,149

Long-term debt

42,658

41,990

Long-term income taxes

26,786

25,560

Long-term unearned revenue

2,945

2,912

Deferred income taxes

2,469

433

Operating lease liabilities

14,469

12,728

Other long-term liabilities

23,271

17,981

Total liabilities

231,123

205,753

Commitments and contingencies

Stockholders equity:

Common stock and paid-in capital shares authorized 24,000; outstanding 7,433 and 7,432

99,193

93,718

Retained earnings

159,394

118,848

Accumulated other comprehensive loss

(5,435

(6,343

Total stockholders equity

253,152

206,223

Total liabilities and stockholders equity

484,275

411,976

Refer to accompanying notes.

PART I

Item 1

CASH FLOWS STATEMENTS

(In millions) (Unaudited)

Three Months Ended

March 31,

Nine Months Ended

March 31,

2024

2023

2024

2023

Operations

Net income

21,939

18,299

66,100

52,280

Adjustments to reconcile net income to net cash from operations:

Depreciation, amortization, and other

6,027

3,549

15,907

9,987

Stock-based compensation expense

2,703

2,465

8,038

7,195

Net recognized losses (gains) on investments and derivatives

49

(40

261

152

Deferred income taxes

(1,323

(1,675

(3,593

(4,171

Changes in operating assets and liabilities:

Accounts receivable

(2,028

(1,408

6,055

7,157

Inventories

260

106

1,229

868

Other current assets

951

1,152

880

428

Other long-term assets

(2,137

(554

(5,577

(1,285

Accounts payable

648

(407

(659

(4,032

Unearned revenue

(645

(181

(10,309

(8,689

Income taxes

2,622

1,414

2,493

(1,039

Other current liabilities

2,803

1,715

215

(490

Other long-term liabilities

48

313

451

Net cash from operations

31,917

24,441

81,353

58,812

Financing

Proceeds from issuance (repayments) of debt, maturities of 90 days or less, net

(3,810

6,392

Proceeds from issuance of debt

6,352

24,198

Repayments of debt

(11,589

(16,005

(1,750

Common stock issued

522

536

1,468

1,354

Common stock repurchased

(4,213

(5,509

(13,044

(16,541

Common stock cash dividends paid

(5,572

(5,059

(16,197

(14,746

Other, net

(498

(258

(1,006

(839

Net cash used in financing

(18,808

(10,290

(14,194

(32,522

Investing

Additions to property and equipment

(10,952

(6,607

(30,604

(19,164

Acquisition of companies, net of cash acquired, and purchases of intangible and other assets

(1,575

(301

(67,790

(1,329

Purchases of investments

(2,183

(9,063

(14,901

(25,675

Maturities of investments

3,350

13,154

23,218

26,744

Sales of investments

1,941

1,239

8,871

8,725

Other, net

(1,281

(1,686

(916

(2,847

Net cash used in investing

(10,700

(3,264

(82,122

(13,546

Effect of foreign exchange rates on cash and cash equivalents

(80

29

(107

(113

Net change in cash and cash equivalents

2,329

10,916

(15,070

12,631

Cash and cash equivalents, beginning of period

17,305

15,646

34,704

13,931

Cash and cash equivalents, end of period

19,634

26,562

19,634

26,562

Refer to accompanying notes.

PART I

Item 1

STOCKHOLDERS EQUITY STATEMENTS

(In millions, except per share amounts) (Unaudited)

Three Months Ended

March 31,

Nine Months Ended

March 31,

2024

2023

2024

2023

Common stock and paid-in capital

Balance, beginning of period

97,480

90,225

93,718

86,939

Common stock issued

522

536

1,468

1,354

Common stock repurchased

(1,512

(1,133

(4,213

(3,394

Stock-based compensation expense

2,703

2,465

8,038

7,195

Other, net

182

(1

Balance, end of period

99,193

92,093

99,193

92,093

Retained earnings

Balance, beginning of period

145,737

99,368

118,848

84,281

Net income

21,939

18,299

66,100

52,280

Common stock cash dividends

(5,573

(5,053

(16,718

(15,176

Common stock repurchased

(2,709

(4,380

(8,836

(13,151

Balance, end of period

159,394

108,234

159,394

108,234

Accumulated other comprehensive loss

Balance, beginning of period

(4,949

(6,457

(6,343

(4,678

Other comprehensive income (loss)

(486

813

908

(966

Balance, end of period

(5,435

(5,644

(5,435

(5,644

Total stockholders equity

253,152

194,683

253,152

194,683

Cash dividends declared per common share

0.75

0.68

2.25

2.04

Refer to accompanying notes.

PART I

Item 1

NOTES TO FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 ACCOUNTING POLICIES

Accounting Principles

Our unaudited interim consolidated financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America ( GAAP ). In the opinion of management, the unaudited interim consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. Interim results are not necessarily indicative of results for a full year. The information included in this Form 10-Q should be read in conjunction with information included in the Microsoft Corporation fiscal year 2023 Form 10-K filed with the U.S. Securities and Exchange Commission on July 27, 2023.

We have recast certain prior period amounts to conform to the current period presentation. The recast of these prior period amounts had no impact on our consolidated balance sheets, consolidated income statements, or consolidated cash flows statements.

Principles of Consolidation

The consolidated financial statements include the accounts of Microsoft Corporation and its subsidiaries. Intercompany transactions and balances have been eliminated.

Estimates and Assumptions

Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Examples of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, and determining the standalone selling price of performance obligations, variable consideration, and other obligations such as product returns and refunds; loss contingencies; product warranties; the fair value of and/or potential impairment of goodwill and intangible assets for our reporting units; product life cycles; useful lives of our tangible and intangible assets; allowances for doubtful accounts; the market value of, and demand for, our inventory; stock-based compensation forfeiture rates; when technological feasibility is achieved for our products; the potential outcome of uncertain tax positions that have been recognized in our consolidated financial statements or tax returns; and determining the timing and amount of impairments for investments. Actual results and outcomes may differ from management s estimates and assumptions due to risks and uncertainties.

Financial Instruments

Investments

We consider all highly liquid interest-earning investments with a maturity of three months or less at the date of purchase to be cash equivalents. The fair values of these investments approximate their carrying values. In general, investments with original maturities of greater than three months and remaining maturities of less than one year are classified as short-term investments. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations.

PART I

Item 1

Debt investments are classified as available-for-sale and realized gains and losses are recorded using the specific identification method. Changes in fair value, excluding credit losses and impairments, are recorded in other comprehensive income. Fair value is calculated based on publicly available market information or other estimates determined by management. If the cost of an investment exceeds its fair value, we evaluate, among other factors, general market conditions, credit quality of debt instrument issuers, and the extent to which the fair value is less than cost. To determine credit losses, we employ a systematic methodology that considers available quantitative and qualitative evidence. In addition, we consider specific adverse conditions related to the financial health of, and business outlook for, the investee. If we have plans to sell the security or it is more likely than not that we will be required to sell the security before recovery, then a decline in fair value below cost is recorded as an impairment charge in other income (expense), net and a new cost basis in the investment is established. If market, industry, and/or investee conditions deteriorate, we may incur future impairments.

Equity investments with readily determinable fair values are measured at fair value. Equity investments without readily determinable fair values are measured using the equity method or measured at cost with adjustments for observable changes in price or impairments (referred to as the measurement alternative). We perform a qualitative assessment on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value of the investment is less than carrying value. Changes in value are recorded in other income (expense), net.

Investments that are considered variable interest entities ( VIEs ) are evaluated to determine whether we are the primary beneficiary of the VIE, in which case we would be required to consolidate the entity. We evaluate whether we have (1) the power to direct the activities that most significantly impact the VIE s economic performance, and (2) the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. We have determined we are not the primary beneficiary of any of our VIE investments. Therefore, our VIE investments are not consolidated and the majority are accounted for under the equity method of accounting.

Derivatives

Derivative instruments are recognized as either assets or liabilities and measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation.

For derivative instruments designated as fair value hedges, gains and losses are recognized in other income (expense), net with offsetting gains and losses on the hedged items. Gains and losses representing hedge components excluded from the assessment of effectiveness are recognized in other income (expense), net.

For derivative instruments designated as cash flow hedges, gains and losses are initially reported as a component of other comprehensive income and subsequently recognized in other income (expense), net with the corresponding hedged item. Gains and losses representing hedge components excluded from the assessment of effectiveness are recognized in other income (expense), net.

For derivative instruments that are not designated as hedges, gains and losses from changes in fair values are primarily recognized in other income (expense), net.

Fair Value Measurements

We account for certain assets and liabilities at fair value. The hierarchy below lists three levels of fair value based on the extent to which inputs used in measuring fair value are observable in the market. We categorize each of our fair value measurements in one of these three levels based on the lowest level input that is significant to the fair value measurement in its entirety. These levels are:

Level 1 inputs are based upon unadjusted quoted prices for identical instruments in active markets. Our Level 1 investments include U.S. government securities, common and preferred stock, and mutual funds. Our Level 1 derivative assets and liabilities include those actively traded on exchanges.

PART I

Item 1

Level 2 inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques (e.g. the Black-Scholes model) for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves, credit spreads, foreign exchange rates, and forward and spot prices for currencies. Our Level 2 investments include commercial paper, certificates of deposit, U.S. agency securities, foreign government bonds, mortgage- and asset-backed securities, corporate notes and bonds, and municipal securities. Our Level 2 derivative assets and liabilities include certain cleared swap contracts and over-the-counter forward, option, and swap contracts.

Level 3 inputs are generally unobservable and typically reflect management s estimates of assumptions that market participants would use in pricing the asset or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models. Our Level 3 assets and liabilities include investments in corporate notes and bonds, municipal securities, and goodwill and intangible assets, when they are recorded at fair value due to an impairment charge. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities.

We measure equity investments without readily determinable fair values on a nonrecurring basis. The fair values of these investments are determined based on valuation techniques using the best information available, and may include quoted market prices, market comparables, and discounted cash flow projections.

Our other current financial assets and current financial liabilities have fair values that approximate their carrying values.

Contract Balances and Other Receivables

As of March 31, 2024 and June 30, 2023, long-term accounts receivable, net of allowance for doubtful accounts, was $4.8 billion and $4.5 billion, respectively, and is included in other long-term assets in our consolidated balance sheets.

As of March 31, 2024 and June 30, 2023, other receivables related to activities to facilitate the purchase of server components were $10.1 billion and $9.2 billion, respectively, and are included in other current assets in our consolidated balance sheets.

We record financing receivables when we offer certain of our customers the option to acquire our software products and services offerings through a financing program in a limited number of countries. As of March 31, 2024 and June 30, 2023, our financing receivables, net were $2.7 billion and $5.3 billion, respectively, for short-term and long-term financing receivables, which are included in other current assets and other long-term assets in our consolidated balance sheets. We record an allowance to cover expected losses based on troubled accounts, historical experience, and other currently available evidence.

Related Party Transactions

In March 2024, we entered into an agreement with Inflection AI, Inc. ( Inflection ), pursuant to which we obtained a non-exclusive license to Inflection s intellectual property. Reid Hoffman, a member of our Board of Directors, is a co-founder of and serves on the board of directors of Inflection. As of the date of the agreement with Inflection, Reprogrammed Interchange LLC ( Reprogrammed ) and entities affiliated with Greylock Ventures ( Greylock ) each held less than a 10% equity interest in Inflection. Mr. Hoffman may be deemed to beneficially own the shares held by Reprogrammed and Greylock by virtue of his relationship with such entities. Mr. Hoffman did not participate in any portions of the meetings of our Board of Directors or any committee thereof to review and approve the transaction with Inflection.

10

PART I

Item 1

Recent Accounting Guidance

Segment Reporting Improvements to Reportable Segment Disclosures

In November 2023, the Financial Accounting Standards Board ( FASB ) issued a new standard to improve reportable segment disclosures. The guidance expands the disclosures required for reportable segments in our annual and interim consolidated financial statements, primarily through enhanced disclosures about significant segment expenses. The standard will be effective for us beginning with our annual reporting for fiscal year 2025 and interim periods thereafter, with early adoption permitted. We are currently evaluating the impact of this standard on our segment disclosures.

Income Taxes Improvements to Income Tax Disclosures

In December 2023, the FASB issued a new standard to improve income tax disclosures. The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. The standard will be effective for us beginning with our annual reporting for fiscal year 2026, with early adoption permitted. We are currently evaluating the impact of this standard on our income tax disclosures.

NOTE 2 EARNINGS PER SHARE

Basic earnings per share ( EPS ) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and stock awards.

The components of basic and diluted EPS were as follows:

(In millions, except per share amounts)

Three Months Ended

March 31,

Nine Months Ended

March 31,

2024

2023

2024

2023

Net income available for common shareholders (A)

21,939

18,299

66,100

52,280

Weighted average outstanding shares of common stock (B)

7,431

7,441

7,431

7,450

Dilutive effect of stock-based awards

41

23

36

24

Common stock and common stock equivalents (C)

7,472

7,464

7,467

7,474

Earnings Per Share

Basic (A/B)

2.95

2.46

8.90

7.02

Diluted (A/C)

2.94

2.45

8.85

6.99

Anti-dilutive stock-based awards excluded from the calculations of diluted EPS were immaterial during the periods presented.

11

PART I

Item 1

NOTE 3 OTHER INCOME (EXPENSE), NET

The components of other income (expense), net were as follows:

(In millions)

Three Months Ended

March 31,

Nine Months Ended

March 31,

2024

2023

2024

2023

Interest and dividends income

619

748

2,519

2,089

Interest expense

(800

(496

(2,234

(1,486

Net recognized gains (losses) on investments

(25

105

(63

103

Net losses on derivatives

(24

(65

(198

(255

Net gains (losses) on foreign currency remeasurements

(138

122

(203

26

Other, net

(486

(93

(792

(162

Total

(854

321

(971

315

Other, net primarily reflects net recognized losses on equity method investments.

Net Recognized Gains (Losses) on Investments

Net recognized gains (losses) on debt investments were as follows:

(In millions)

Three Months Ended

March 31,

Nine Months Ended

March 31,

2024

2023

2024